Annual Secretarial Compliance Report for the Year Ended 31st March, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs Limited submitted its Annual Secretarial Compliance Report for FY2024-25, reviewed by VSS & Associates (Company Secretaries) and signed by CS Vidya Harkut on April 18, 2025. The report covers the company's adherence to SEBI regulations including LODR, Insider Trading, Takeover, and Capital Issue norms, as well as Secretarial Standards issued by ICSI. The company has reported full compliance across all areas — secretarial standards, policy adoption and updation, website disclosures, director eligibility, subsidiary disclosures, document preservation, board performance evaluation, related party transactions, and event/information disclosures. No deviations, penalties, or actions by SEBI or stock exchanges were reported during the review period, and no prior observations remained pending.
A clean compliance report with no adverse observations or penalties is mildly positive for governance credibility, but this is a routine annual filing with no material business or financial impact on shareholders.